Ayme-DietrichE, Aubertin-KirchG, MaroteauxL, MonassierL: Arch: Cardiovascular remodeling and the peripheral serotonergic system. Cardiovasc Dis, 110:51–59, 2017.
2.
CorrellCU: Antipsychotic medications. In: Dulcon's Textbook of Child and Adolescent Psychiatry, 2nd edition. Edited by DulconMK. Washington, American Psychiatric Publishing, 2015, pp. 795–875.
3.
CoskunM, MukaddesNM: Possible risperidone-related gastrointestinal bleeding or epistaxis in two pediatric cases. J Child Adolesc Psychopharmacol, 18:299–300, 2008.
4.
FindlingRL, McNamaraNK, YoungstromEA, StansbreyRJ, FrazierTW, LinglerJ, OttoBD, DemeterCA, RowlesBM, CalabreseJR: An open-label study of aripiprazole in children with a bipolar disorder. J Child Adolesc Psychopharmacol, 21:345–351, 2011.
5.
Harrison-WoolrychM, ClarkDW: Nose bleeds associated with use of risperidone. BMJ, 328:1416, 2004.
6.
ShapiroDA, RenockS, ArringtonE, ChiodoLA, LiuLX, SibleyDR, RothBL, MailmanR: Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology, 28:1400–1411, 2003.